Interestingly, in inflamed areas of cancer tissue, it has been observed an increase CD39 and CD73 expression and activity along with a reduction in ADA and CD26 expression, resulting in a marked and persistent increase in extracellular adenosine concentrations (Figure 4). The gene discussed is ENTPD1; the disease is cancer.